Unichem Laboratories Ltd.

NSE: UNICHEMLAB | BSE: 506690 | ISIN: INE351A01035 | Industry: Pharmaceuticals
| Expensive Performer
612.1000 -7.00 (-1.13%)
NSE Apr 29, 2025 15:31 PM
Volume: 15,999
 

612.10
-1.13%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 17.5% YoY to | 360 crore (I-direct estimate: | 361 crore) mainly on account of 31.5% growth in export sales to | 123 crore (I-direct estimate: | 115 crore). Domestic revenues grew 7.8% YoY to | 204 crore (I-direct estimate: | 217 crore) EBITDA margins improved 121 bps YoY to 12.3% (I-direct estimate: 12.5%) mainly due to lower other expenditure. EBITDA increased 30% YoY to | 44 crore in line with I-direct estimate of | 45 crore...
Unichem Laboratories Ltd. has lost -22.92% in the last 6 Months
More from Unichem Laboratories Ltd.
Recommended